Global Pulmonary Arterial Hypertension (PAH) Treatment Market is thriving due to a rising prevalence of pulmonary hypertension, advancements in drug development, increasing awareness about the disease ...

USA: In patients with advanced pulmonary arterial hypertension (PAH), adding the biologic sotatercept-csrk (Winrevair; Merck) ...

Comparison measures of lung function and improved categorization of cardiovascular disease (CVD) risk were among the key ...

Aims Pulmonary hypertension (PHT) appears to be very common in heart failure with preserved ejection fraction but details on ...

LungFit PH, Beyond Air's nitric oxide therapy device, has received the European CE mark approval for pulmonary hypertension ...

Drivers could face fines if they haven’t declared health conditions to the DVLA (Picture: ) The DVLA has warned drivers they ...

You reach a major life milestone when you enter your forties, a critical age when certain health screenings become essential.

The table below is a review of notable updates that occurred in November 2024 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. The ...

Watch our fascinating panel discussion on managing pulmonary hypertension as an MDT from our Clinical Excellence in ...